Cargando…
Prevention of Venous Thromboembolism in 2020 and Beyond
Venous thromboembolism (VTE) is the third most common cause of vascular mortality worldwide and comprises deep-vein thrombosis (DVT) and pulmonary embolism (PE). In this review, we discuss how an understanding of VTE epidemiology and the results of thromboprophylaxis trials have shaped the current a...
Autores principales: | Nicholson, Matthew, Chan, Noel, Bhagirath, Vinai, Ginsberg, Jeffrey |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7465935/ https://www.ncbi.nlm.nih.gov/pubmed/32752154 http://dx.doi.org/10.3390/jcm9082467 |
Ejemplares similares
-
Profile of betrixaban and its potential in the prevention and treatment of venous thromboembolism
por: Chan, Noel C, et al.
Publicado: (2015) -
Current Challenges in Diagnosis of Venous Thromboembolism
por: Liederman, Zachary, et al.
Publicado: (2020) -
New Anticoagulants for the Prevention and Treatment of Venous Thromboembolism
por: McRae, Simon J, et al.
Publicado: (2005) -
No apparent association between mRNA COVID-19 vaccination and venous thromboembolism
por: Nicholson, Matthew, et al.
Publicado: (2022) -
Plasma Rivaroxaban Level to Identify Patients at Risk of Drug Overexposure: Is a Single Measurement of Drug Level Reliable?
por: Shyamkumar, Krishnan, et al.
Publicado: (2021)